What is Schizophrenia?
Schizophrenia is a chronic, neurological disorder that obstructs the patient’s perception with reality; it displays a variety of cognitive, positive, and negative symptoms. People living with schizophrenia are typically bound to take harsh medications just to make it through each day; the disorder affects the thoughts, behaviors, and emotions of over 200,000 people in the United States.
Symptoms typically consist of hallucinations, delusions, and repetitive movements; some patients may have experienced discouragement, discontent, and severe apathy. Many patients search for more sustainable treatments; however, several alternative options rarely receive much support.
Studies have suggested a link between schizophrenia and endocannabinoid deficiency; this connection indicates low activity from cannabinoid receptors, weak development of endogenous cannabinoids, and the high levels of particular substances and enzymes that break down cannabinoids made within the body. According to the research, CBD oil enhances the endocannabinoid system (ECS) leading to the production of more endogenous cannabinoids and restricting endocannabinoid metabolism. Observations have also shown CBD effective against psychotic effects, mental impairment, and acute axiogenics; therefore, CBD offers schizophrenia patients better cognitive activity and behavioral control.
A recent scientific study declares the efficiency of CBD for schizophrenia by comparing it to Amisulpride - a potent antipsychotic treatment for schizophrenia. With 42 willing participants, both types of therapeutics were effective against symptoms; however, it was the CBD that provided relief without any adverse effects in comparison to more traditional medication.